Tumor cells have the ability to induce platelet activation and aggregation. This has been
documented to be involved in tumor progression in several types of cancers, such as lung …

The interaction between circulating tumor cells and platelets is a key factor in cancer
metastasis. These interactions, driven by a variety of receptors, support circulating tumor …

Platelets are essential components in the tumor microenvironment. For decades, clinical
data have demonstrated that cancer patients have a high risk of thrombosis that is …

Although platelets are critically involved in thrombosis and hemostasis, experimental and
clinical evidence indicate that platelets promote tumor progression and metastasis through a …

Extensive experimental evidence indicates that platelets contribute to tumor cell proliferation
and metastasis through direct interactions and secreted bioactive proteins. Activated …

Platelets play a crucial role in cancer blood metastasis. Various cancer-related factors such
as Toll-like receptors (TLRs), adenosine diphosphate (ADP) or extracellular matrix (ECM) …

While platelets are well known to play a central role in hemostasis and thrombosis, there is
emerging experimental evidence to suggest that they also mediate tumor cell growth …

Platelets are highly reactive components of the circulatory system, which exert not only
haemostatic activity but also contribute to the modulation of various pathological conditions …

Platelets have long been recognized as key players in hemostasis and thrombosis;
however, growing evidence suggests that they are also significantly involved in cancer, the …

Systemic antiplatelet treatment represents a promising option to improve the therapeutic
outcomes and therapeutic efficacy of chemotherapy and immunotherapy due to the critical …